Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT03719105 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

NK-Cell Lymphoma
NK-Cell Leukemia
Peripheral T Cell Lymphoma

Interventions

DRUG: Methotrexate
DRUG: pralatraxate,
DRUG: Ifosfamide
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: calaspargase pegol
DRUG: cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Brentuximab Vedotin

Sponsor

New York Medical College

Collaborators

[object Object]